Literature DB >> 7827358

Effects of non-esterified fatty acids on insulin-stimulated glucose transport in isolated skeletal muscle from patients with type 2 (non-insulin-dependent) diabetes mellitus.

D Galuska1, L Nolte, E Wahlström, J S Smedegaard Kristensen, H Wallberg-Henriksson, J R Zierath.   

Abstract

The influence of elevated levels of oleate on insulin-stimulated 3-0-methylglucose transport was assessed in vitro, in isolated skeletal muscle obtained from patients with type 2 (non-insulin-dependent) diabetes mellitus (n = 7) and control subjects (n = 8). An increase in oleate levels from 0.3 to 1.0 mmol/l induced a 3.7-fold increase in the rate of oleate oxidation (P < 0.01) in skeletal muscle from control subjects. However, the rate of insulin-stimulated 3-0-methylglucose transport was not altered in isolated skeletal muscle from the control subjects or the type 2 diabetic patients following exposure to 1.0 mmol/l oleate. This observation indicates that elevation of non-esterified fatty acids to a high physiological level has no inhibitory effect on glucose transport.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7827358     DOI: 10.1007/bf00570374

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  18 in total

1.  Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles.

Authors:  P J Randle; E A Newsholme; P B Garland
Journal:  Biochem J       Date:  1964-12       Impact factor: 3.857

2.  Inhibition of hepatic glucose production by SDZ 51641.

Authors:  D A Young; R S Ho; P A Bell; D K Cohen; R H McIntosh; J Nadelson; J E Foley
Journal:  Diabetes       Date:  1990-11       Impact factor: 9.461

3.  Elevated free fatty acid levels inhibit glucose phosphorylation in slow-twitch rat skeletal muscle.

Authors:  L A Nolte; D Galuska; I K Martin; J R Zierath; H Wallberg-Henriksson
Journal:  Acta Physiol Scand       Date:  1994-05

4.  Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo.

Authors:  P Nuutila; V A Koivisto; J Knuuti; U Ruotsalainen; M Teräs; M Haaparanta; J Bergman; O Solin; L M Voipio-Pulkki; U Wegelius
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

5.  Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.

Authors:  L C Groop; R C Bonadonna; S DelPrato; K Ratheiser; K Zyck; E Ferrannini; R A DeFronzo
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

6.  Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance.

Authors:  J R Zierath; D Galuska; L A Nolte; A Thörne; J S Kristensen; H Wallberg-Henriksson
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

7.  Insulin action on glucose transport in isolated skeletal muscle from patients with liver cirrhosis.

Authors:  U Johansson; L S Eriksson; D Galuska; J R Zierath; H Wallberg-Henriksson
Journal:  Scand J Gastroenterol       Date:  1994-01       Impact factor: 2.423

8.  Effect of fatty acids on glucose production and utilization in man.

Authors:  E Ferrannini; E J Barrett; S Bevilacqua; R A DeFronzo
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

9.  Reversibility of decreased insulin-stimulated glucose transport capacity in diabetic muscle with in vitro incubation. Insulin is not required.

Authors:  H Wallberg-Henriksson; N Zetan; J Henriksson
Journal:  J Biol Chem       Date:  1987-06-05       Impact factor: 5.157

10.  An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects.

Authors:  G L Dohm; E B Tapscott; W J Pories; D J Dabbs; E G Flickinger; D Meelheim; T Fushiki; S M Atkinson; C W Elton; J F Caro
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.